Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 Feb;36(2):477-479.
doi: 10.1007/s10067-016-3420-9. Epub 2016 Oct 24.

Sulfasalazine induced immune thrombocytopenia in a patient with rheumatoid arthritis

Nehal Narayan  1 , Shirley Rigby  2 , Francesco Carlucci  3
Affiliations
Case Reports

Sulfasalazine induced immune thrombocytopenia in a patient with rheumatoid arthritis

Nehal Narayan et al. Clin Rheumatol. 2017 Feb.

Abstract

Sulfasalazine has long been used for the treatment of rheumatoid arthritis and is often chosen as a first-line treatment. Here, we report a case of sulfasalazine-induced autoimmune thrombocytopenia and review the mechanisms behind drug-induced immune thrombocytopenia (DITP) and the approach to its diagnosis and management.

Keywords: Autoantibodies; Blood platelets disorders; Hematologic diseases; Rheumatic diseases; Rheumatoid arthritis (RA); Thrombocytopenia; Tissues or models.

PubMed Disclaimer

Conflict of interest statement

Compliance with ethical standards Disclosures None.

Similar articles

See all similar articles

Cited by

References

    1. Gunnarsson I, Kanerud L, Pettersson E, Lundberg I, Lindblad S, Ringertz B. Predisposing factors in sulphasalazine-induced systemic lupus erythematosus. Rheumatology. 1997;36:1089–1094. doi: 10.1093/rheumatology/36.10.1089. - DOI - PubMed
    1. Cantarini L, Tinazzi I, Biasis D, Fioravanti A, Galeazzi M. Sulfasalazine-induced immune thrombocytopenia. Postgraduate. Med J. 2007;83:e1. - PMC - PubMed
    1. Cohen YC, Djulbegovic B, Shamai-Lubovitz O, Mozes B. The bleeding risk and natural history of idiopathicthrombocytopenic purpura in patients with persistent low platelet counts. Arch Intern Med. 2000;160:1630–1638. doi: 10.1001/archinte.160.11.1630. - DOI - PubMed
    1. Izak M, Bussel JB. Management of thrombocytopenia. F1000Prime Rep. 2014;6:45. doi: 10.12703/P6-45. - DOI - PMC - PubMed
    1. Aster RH, Bougie DW. Drug-induced immune thrombocytopenia. N Engl J Med. 2007;357:580–587. doi: 10.1056/NEJMra066469. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources